Cystic fibrosis

Curr Opin Pulm Med. 1999 Nov;5(6):363-4. doi: 10.1097/00063198-199911000-00007.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cystic Fibrosis / genetics
  • Cystic Fibrosis / therapy*
  • Diabetes Complications
  • Genetic Therapy
  • Humans
  • Lung Transplantation
  • Survival Rate

Substances

  • Anti-Bacterial Agents